Identification of Hazardous Medicinal Products (HMPs) In the healthcare sector, 12.7 million workers across the EU are potentially exposed to Hazardous Medicinal Products (HMPs). While these drugs are vital in the treatment of different diseases such as cancers, psoriasis, etc., they can also pose health risks to those exposed to them at work like nurses, […]

Workers exposed to hazardous medicinal products (HMPs), or hazardous drugs, which are carcinogenic, mutagenic or reprotoxic substances (CMRs) must be given specific training by their employers to prevent risks of adverse effects on their health. Healthcare sector ETUI published a list of hazardous medicinal products, including cytotoxics and based on the EU CLP classification system […]